CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 17, 2006--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company developing and commercializing oral and injectable protein therapeutics for...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 14, 2006--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on the development and commercialization of oral and injectable...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 11, 2006--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company developing and commercializing oral and injectable protein therapeutics for...
#1: ALTU News Altus Pharmaceuticals Updates Plans for Initiation of Phase III Clinical Trials for ALTU-135 and ALTU-238; Altus to Host Conference Call and Webcast Today at 5:15 P.M. Eastern Time
CAMBRIDGE, Mass.--(BUSINESS WIRE)--July 24, 2006--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on the development and commercialization of oral and injectable...